Equities

F D C Ltd

F D C Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)567.00
  • Today's Change13.10 / 2.37%
  • Shares traded315.65k
  • 1 Year change+56.78%
  • Beta0.7028
Data delayed at least 15 minutes, as of Sep 20 2024 06:22 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year F D C Ltd grew revenues 8.92% from 17.84bn to 19.43bn while net income improved 57.30% from 1.94bn to 3.05bn.
Gross margin65.55%
Net profit margin15.37%
Operating margin15.74%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in INRView more

In 2024, F D C Ltd increased its cash reserves by 6.42%, or 15.34m. The company earned 2.21bn from its operations for a Cash Flow Margin of 11.36%. In addition the company used 170.83m on investing activities and also paid 2.02bn in financing cash flows.
Cash flow per share21.66
Price/Cash flow per share26.67
Book value per share--
Tangible book value per share--
More ▼

Balance sheet in INRView more

F D C Ltd uses little or no debt in its capital structure.
Current ratio--
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in INR

Year on year, growth in earnings per share excluding extraordinary items increased 59.22%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years)13.81
EPS (TTM) vs
TTM 1 year ago
36.98
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.